Green Cross Holdings Corporation (005250.KS)
KRW 13380.0
(3.72%)
KRW 13380.0
(3.72%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -54.13 Billion KRW | -191.92% |
| 2022 | 58.89 Billion KRW | -53.86% |
| 2021 | 127.65 Billion KRW | 81.43% |
| 2020 | 70.36 Billion KRW | 330.87% |
| 2019 | -30.47 Billion KRW | -265.04% |
| 2018 | 18.46 Billion KRW | -57.42% |
| 2017 | 43.36 Billion KRW | -8.08% |
| 2016 | 47.17 Billion KRW | -27.89% |
| 2015 | 65.42 Billion KRW | 15.26% |
| 2014 | 56.76 Billion KRW | 30.34% |
| 2013 | 43.54 Billion KRW | -29.24% |
| 2012 | 61.54 Billion KRW | 122.39% |
| 2011 | 27.67 Billion KRW | -59.01% |
| 2010 | 67.52 Billion KRW | 79.55% |
| 2009 | 37.6 Billion KRW | 76.06% |
| 2008 | 21.36 Billion KRW | -13.09% |
| 2007 | 24.57 Billion KRW | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -16.65 Billion KRW | 59.15% |
| 2024 Q1 | -40.76 Billion KRW | -327.6% |
| 2023 Q1 | -38.07 Billion KRW | -239.51% |
| 2023 Q3 | -8.42 Billion KRW | 20.01% |
| 2023 Q2 | -10.53 Billion KRW | 72.33% |
| 2023 Q4 | -9.53 Billion KRW | -13.13% |
| 2023 FY | -54.13 Billion KRW | -191.92% |
| 2022 Q2 | -6.3 Billion KRW | -224.24% |
| 2022 Q3 | 23.76 Billion KRW | 476.75% |
| 2022 Q4 | 27.29 Billion KRW | 14.85% |
| 2022 Q1 | -1.94 Billion KRW | -109.51% |
| 2022 FY | 58.89 Billion KRW | -53.86% |
| 2021 Q1 | 13.24 Billion KRW | -89.19% |
| 2021 Q4 | 20.46 Billion KRW | 1.49% |
| 2021 FY | 127.65 Billion KRW | 81.43% |
| 2021 Q3 | 20.16 Billion KRW | 1337.67% |
| 2021 Q2 | 1.4 Billion KRW | -89.41% |
| 2020 Q2 | 27.46 Billion KRW | 1219.33% |
| 2020 Q1 | -2.45 Billion KRW | -161.64% |
| 2020 Q3 | 23.4 Billion KRW | -14.79% |
| 2020 FY | 70.36 Billion KRW | 330.87% |
| 2020 Q4 | 122.54 Billion KRW | 423.65% |
| 2019 Q2 | -9.63 Billion KRW | -453.91% |
| 2019 Q4 | 3.98 Billion KRW | -32.44% |
| 2019 FY | -30.47 Billion KRW | -265.04% |
| 2019 Q3 | 5.89 Billion KRW | 161.13% |
| 2019 Q1 | 2.72 Billion KRW | 199.61% |
| 2018 Q2 | -4.54 Billion KRW | -120.98% |
| 2018 Q3 | 4.09 Billion KRW | 190.23% |
| 2018 FY | 18.46 Billion KRW | -57.42% |
| 2018 Q1 | 21.64 Billion KRW | 289.98% |
| 2018 Q4 | -2.73 Billion KRW | -166.73% |
| 2017 FY | 43.36 Billion KRW | -8.08% |
| 2017 Q4 | 5.55 Billion KRW | -64.52% |
| 2017 Q3 | 15.64 Billion KRW | -6.43% |
| 2017 Q2 | 16.71 Billion KRW | 206.63% |
| 2017 Q1 | 5.45 Billion KRW | -78.07% |
| 2016 Q1 | 2.3 Billion KRW | -22.0% |
| 2016 Q2 | 11.49 Billion KRW | 398.76% |
| 2016 Q3 | 8.51 Billion KRW | -25.88% |
| 2016 Q4 | 24.86 Billion KRW | 191.94% |
| 2016 FY | 47.17 Billion KRW | -27.89% |
| 2015 FY | 65.42 Billion KRW | 15.26% |
| 2015 Q4 | 2.95 Billion KRW | -90.44% |
| 2015 Q3 | 30.9 Billion KRW | 42.48% |
| 2015 Q2 | 21.68 Billion KRW | 119.62% |
| 2015 Q1 | 9.87 Billion KRW | 147.43% |
| 2014 FY | 56.76 Billion KRW | 30.34% |
| 2014 Q3 | 28.44 Billion KRW | 191.82% |
| 2014 Q2 | 9.74 Billion KRW | -33.11% |
| 2014 Q1 | 14.57 Billion KRW | 778.96% |
| 2014 Q4 | 3.99 Billion KRW | -85.97% |
| 2013 Q4 | 1.65 Billion KRW | -90.76% |
| 2013 FY | 43.54 Billion KRW | -29.24% |
| 2013 Q1 | 14.65 Billion KRW | 130.44% |
| 2013 Q2 | 9.29 Billion KRW | -36.52% |
| 2013 Q3 | 17.94 Billion KRW | 92.92% |
| 2012 Q3 | 15.86 Billion KRW | 117.57% |
| 2012 Q2 | 7.29 Billion KRW | -91.57% |
| 2012 Q1 | 86.52 Billion KRW | 1335.35% |
| 2012 FY | 61.54 Billion KRW | 122.39% |
| 2012 Q4 | -48.13 Billion KRW | -403.42% |
| 2011 Q1 | 17.87 Billion KRW | 0.0% |
| 2011 Q3 | 18.09 Billion KRW | 71.76% |
| 2011 Q4 | -7 Billion KRW | -138.7% |
| 2011 Q2 | 10.53 Billion KRW | -41.07% |
| 2011 FY | 27.67 Billion KRW | -59.01% |
| 2010 Q2 | 14.57 Billion KRW | -59.68% |
| 2010 Q3 | 17.53 Billion KRW | 20.36% |
| 2010 FY | 67.52 Billion KRW | 79.55% |
| 2010 Q4 | - KRW | -100.0% |
| 2010 Q1 | 36.13 Billion KRW | 0.0% |
| 2009 Q3 | 6.25 Billion KRW | -30.94% |
| 2009 Q2 | 9.05 Billion KRW | 7475.13% |
| 2009 Q1 | 119.59 Million KRW | 0.0% |
| 2009 FY | 37.6 Billion KRW | 76.06% |
| 2009 Q4 | - KRW | -100.0% |
| 2008 Q3 | 194.07 Million KRW | -98.34% |
| 2008 Q2 | 11.72 Billion KRW | 3574.76% |
| 2008 Q1 | 318.97 Million KRW | 0.0% |
| 2008 Q4 | - KRW | -100.0% |
| 2008 FY | 21.36 Billion KRW | -13.09% |
| 2007 Q1 | 3.14 Billion KRW | 0.0% |
| 2007 FY | 24.57 Billion KRW | 0.0% |
| 2007 Q4 | - KRW | -100.0% |
| 2007 Q2 | 6.23 Billion KRW | 97.95% |
| 2007 Q3 | 2.63 Billion KRW | -57.72% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| ORIENT BIO Inc. | 12.87 Billion KRW | 520.605% |
| Green Cross Holdings Corporation | -26.63 Billion KRW | -103.277% |
| Pharmicell Co., Ltd. | 3.57 Billion KRW | 1613.039% |
| Green Cross Corporation | -26.63 Billion KRW | -103.277% |
| GeneOne Life Science, Inc. | -77.76 Billion KRW | 30.387% |
| Celltrion, Inc. | 535.64 Billion KRW | 110.107% |
| Samsung Biologics Co.,Ltd. | 857.69 Billion KRW | 106.312% |
| SK bioscience Co.,Ltd. | 22.31 Billion KRW | 342.571% |
| SK Biopharmaceuticals Co., Ltd. | -32.88 Billion KRW | -64.634% |
| Prestige BioPharma Limited | -32.92 Billion KRW | -64.442% |